@article{55f232cfba9c4348879b29dde62dda9b,
title = "Canadian Stroke Best Practice Guidance during the COVID-19 Pandemic",
keywords = "COVID-19, Clinical practice guidelines, Coronavirus 2019, Knowledge translation, Prevention, Rehabilitation, Stroke, Telestroke",
author = "Smith, {Eric E.} and Anita Mountain and Hill, {Michael D.} and Wein, {Theodore H.} and Dylan Blacquiere and Casaubon, {Leanne K.} and Elizabeth Linkewich and Norine Foley and Gord Gubitz and Anne Simard and Lindsay, {M. Patrice}",
note = "Funding Information: AM reports involvement in clinical trial grants from Brain Canada, Heart and Stroke Foundation of Canada, and the Canadian Partnership for Stroke Recovery; MDH reports a relationship with NoNO Inc as an unpaid advisor, Boehringer-Ingelheim as a paid advisor, and holds research grants from CIHR, Alberta Innovates, Heart and Stroke Foundation of Canada, Heart and Stroke Foundation of Alberta, multiple industry partners for clinical trials managed through the University of Calgary; LKC participated in an advisory board for Bayer in 2018, and is an independent neurological assessor for patients in SURTAVI trial; GG is a collaborator in the ESCAPE-NA1 trial with the University of Calgary. ",
year = "2020",
month = jul,
day = "1",
doi = "10.1017/cjn.2020.74",
language = "English",
volume = "47",
pages = "474--478",
journal = "Canadian Journal of Neurological Sciences",
issn = "0317-1671",
publisher = "Canadian Journal of Neurological Sciences",
number = "4",
}